Embla Medical hf (OCSE:EMBLA)
kr 35.3 0.8 (2.32%) Market Cap: 15.07 Bil Enterprise Value: 18.38 Bil PE Ratio: 31.89 PB Ratio: 2.86 GF Score: 71/100

Q4 2019 Ossur hf Earnings Call Transcript

Feb 04, 2020 / 08:00AM GMT
Release Date Price: kr49.55 (-0.10%)
Operator

Ladies and gentlemen, welcome to the Ãssur Q4 and Full year 2019 Results. Today, I'm pleased to present Mr. Jón Sigurdsson, President and CEO. (Operator Instructions)

Jón, please begin.

Jón SigurÃ;sson;ssur hf.;CEO;President
Ã

° - -&

Yes. Thank you. First of all, I would like to welcome you here to the Ãssur investor conference call where we will cover the results for the full year and the fourth quarter of 2019. My name is Jón Sigurdsson, and I am the President and CEO of Ãssur. And with me here today is Sveinn Sölvason, our CFO.

We will begin by going through the highlights for the quarter, followed by the quarter results and ending with our guidance for 2020. A question-and-answer session will then follow.

Sales for the full year amounted to $686 million, corresponding to 16% growth in local currency and 5% organic growth. EBITDA before special items grew by $35 million or 30% and amounted to $150 million, which corresponds to 22% of sales. Excluding the impact

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot